Search clinical trials for: Relapsed/refractory diffuse large b cell

Total 10000 results

Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

China
Sun Yat-sen University

Not yet recruiting

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

China
Sinocelltech Ltd.

Recruiting

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

DLBCL - Diffuse Large B Cell Lymphoma

China
Brown University
Genentech, Inc.; Incyte Corporation; Natera, Inc.

Not yet recruiting

TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma (TPG)

Lymphoma | Lymphoma, B-Cell | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma

United States
Sun Yat-sen University

Recruiting

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

DLBCL

China

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe